-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EA4a09tv4+KfOC1OkyYI54cQgmVzLjv6q0zUgFx8oexwN+w24t5F0/9Yo32zthzQ MEOpdiS/8IrHb7AQqBcmWA== 0000745637-97-000002.txt : 19970109 0000745637-97-000002.hdr.sgml : 19970109 ACCESSION NUMBER: 0000745637-97-000002 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19970108 SROS: NASD SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CELL GENESYS INC CENTRAL INDEX KEY: 0000865231 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943061375 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-43085 FILM NUMBER: 97502692 BUSINESS ADDRESS: STREET 1: 322 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 4153589600 MAIL ADDRESS: STREET 1: 322 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: HOECHST CORP CENTRAL INDEX KEY: 0000745637 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 221862783 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: ROUTE 202-206 STREET 2: PO BOX 2500 CITY: SOMERVILLE STATE: NJ ZIP: 08876-1258 BUSINESS PHONE: 9082312000 MAIL ADDRESS: STREET 1: ROUTE 202-206 STREET 2: PO BOX 2500 CITY: SOMERVILLE STATE: NJ ZIP: 08876-1258 SC 13D/A 1 HOECHST CORP AMENDMENT 2 TO CORTECH 13D SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Amendment #2 Under the Securities Exchange Act of 1934 CELL GENESYS, INC. ---------------------------- (Name of Issuer) Common Stock par value $.001 per share - --------------------------------------------------------------------------- (Title of Class of Securities) 150921 10 4 ----------------- (CUSIP Number) Harry R. Benz Hoechst Corporation Route 202-206 P.O. Box 2500 Somerville, NJ 08876-1258 (517) 636-1000 - --------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) December 31, 1996 ------------------------------------------------------- (Date of Event Which Requires Filing of This Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box. [ ] Page 1 of 4 There are no Exhibits 2 CUSIP No. 150921 10 4 ___________________________________________________________________________ 1) Name of Reporting Person and its Hoechst Corporation I.R.S. Identification Number 22-1862783 ___________________________________________________________________________ 2) Check the Appropriate Box if (a)[ ] a Member of a Group (b)[ ] ___________________________________________________________________________ 3) SEC Use Only ___________________________________________________________________________ 4) Source of Funds Not applicable ___________________________________________________________________________ 5) Check Box if Disclosure of Legal [ ] Proceedings is Required Pursuant to Items 2(d) or 2(e) ___________________________________________________________________________ 6) Citizenship or Place of Organization Delaware ___________________________________________________________________________ 7) Sole Voting Power 0 Number of ____________________________________________________________ Shares Beneficially 8) Shared Voting Power 0 Owned by ____________________________________________________________ Each Reporting 9) Sole Dispositive Power 0 Person With ____________________________________________________________ 10) Shared Dispositive Power 0 ___________________________________________________________________________ 11) Aggregate Amount Beneficially Owned 0 by Each Reporting Person ___________________________________________________________________________ 12) Check Box If the Aggregate Amount [ ] in Row (11) Excludes Certain Shares ___________________________________________________________________________ 13) Percent of Class Represented 0% by Amount in Row (11) ___________________________________________________________________________ 14) Type of Reporting Person CO ___________________________________________________________________________ 3 This Amendment to the Statement on Schedule 13D (the "Schedule 13D") of Hoechst Corporation, a Delaware corporation ("HCorp"), with respect to the Common Stock of Cell Genesys, Inc., a Delaware corporation (the "Issuer"), is filed solely to report the termination of HCorp's obligation to report beneficial ownership of the Issuer's Common Stock on Schedule 13D. Item 5(e) of the Statement on Schedule 13D of HCorp is hereby amended to read as follows: ITEM 5. INTEREST IN SECURITIES OF THE ISSUER. - ------- ------------------------------------- (e) HCorp ceased to be the possible deemed beneficial owner of more than five percent of the Issuer's Common Stock on December 31, 1996. 4 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. HOECHST CORPORATION Date: January 6, 1997 By: /s/ David A. Jenkins David A. Jenkins Vice President, General Counsel and Secretary -----END PRIVACY-ENHANCED MESSAGE-----